Reducing Denials with MMIT's Coverage and Claims Data
In this use case, learn how one pharma company sought visibility into the frequency and cause of rejected claims for its new endocrine therapy.
After implementing MMIT’s Analytics—augmented with real-world data signals from claims, labs, and EMR systems—the manufacturer can now quantify access for its drug by channel and approval rate.
Download the Use Case
Gain insight into how payer policies impact patients in reality, from care delays to cost constraints.
View the percentages of dispensed, rejected, and abandoned claims, plus the top reasons behind those rejections.
Identify and remediate the top driver of denials across each channel by understanding where access breaks down.